Mecwins Strengthens its European Partnering at the Cluster Health Horizon Europe Brokerage Event 2025
Madrid, May 8, 2025 Mecwins participated in the [...]
MECWINS strengthens global footprint with U.S. Trademark Registration
We are proud to announce the successful registration [...]
Mecwins at the 2nd CTB Workshop on Bioinstrumentation and Nanomedicine
Last Thursday we had the pleasure of attending [...]
Mecwins at CSIC spin-off launch: Driving Innovation
Mecwins is pleased to announce its participation in [...]
Advancing Drug-Induced Liver Injury Detection
Drug-induced liver injury (DILI) remains a major challenge [...]
Mecwins Advances the Determination of pTau217 and pTau181 Biomarker Levels for Alzheimer’s Disease
© Juan Gärtner/stock.adobe.com At Mecwins, we are pushing [...]
Revolutionary AVAC technology for ultra-sensitive and high-throughput biomarker detection unveiled!
At Mecwins, we are excited to share the publication [...]
Mecwins Leads Revolution in Cancer Drug Monitoring
We're excited to announce that Mecwins is playing [...]
